Home›Companies›Healthcare›Health Precision

Health Precision Inc.

Updated Oct 29, 2026·Latest SEC filing Sep 2, 2025·Suggest an edit

About Health Precision

Health Precision is a private company based in New York, New York. It has reported $29,797,927 raised in three offerings on Form D since July 2023. Its chief executive is Eyal Ephrat, MD.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jun 23, 2025Sep 2, 2025$20,000,000fully sold2$10.0MOptions, Convertible debtRule 506(b)Form D ↗
Jul 30, 2024Feb 5, 2025$4,372,927of $10.0M target22$198KEquity, OptionsRule 506(b)Form D ↗
Jun 23, 2023Jul 10, 2023amended Aug 8, 2023$5,425,000of $8.0M target22$246KDebt, OptionsRule 506(b)Form D/A ↗1 earlier filing
Total, three offerings$29,797,927

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Health Precision's Form D filed Sep 2, 2025.

AJ
Avin Joshi
Executive officer
EJ
RR
SY
Sonia Ben-Yehuda
Executive officer and director
EM
Eyal Ephrat, MD
CEO and director

Earlier filings also listed Paul Guenther (director, last listed Feb 2025), Olin Nisbet (director, last listed Feb 2025) and Ninfa Saunders (director, last listed Feb 2025).

Sources

  1. SECHealth Precision Inc. Form D, filed Jul 10, 2023
  2. SECHealth Precision Inc. filing history